Human Vaccines & Immunotherapeutics (Nov 2022)

Breakthrough SARS-CoV-2 infections after vaccination: a critical review

  • Zeinab Mohseni Afshar,
  • Mohammad Barary,
  • Rezvan Hosseinzadeh,
  • Amirmasoud Alijanpour,
  • Dariush Hosseinzadeh,
  • Soheil Ebrahimpour,
  • Kosar Nazary,
  • Terence T. Sio,
  • Mark J. M. Sullman,
  • Kristin Carson-Chahhoud,
  • Arefeh Babazadeh

DOI
https://doi.org/10.1080/21645515.2022.2051412
Journal volume & issue
Vol. 18, no. 5

Abstract

Read online

At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination.

Keywords